Mirae Asset Global Investments »

Catalyst Pharmaceutical Partners shares owned by Mirae Asset Global Investments

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Mirae Asset Global Investments from 13F filings

Historical chart of Mirae Asset Global Investments investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Mirae Asset Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Mirae Asset Global Investments

Quarter filed Position value Share count Share price at filing
2024-03-31 $936k 57k 16.37
2023-12-31 $961k 57k 16.81
2023-09-30 $688k 59k 11.69
2023-06-30 $899k 67k 13.44
2023-03-31 $996k 60k 16.58
2022-12-31 $766k 41k 18.60
2022-09-30 $511k 40k 12.83
2022-06-30 $193k 28k 6.99

More positions owned by Mirae Asset Global Investments

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Broadcom (AVGO)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Scottsdale Fds Vng Rus2000idx (VTWO)
Ishares Tr Core S&p500 Etf (IVV)
Advanced Micro Devices (AMD)
Intuitive Surgical Com New (ISRG)
Qualcomm (QCOM)

View all positions for Mirae Asset Global Investments

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Henderson Group
Geode Capital Management
Royce & Associates
Morgan Stanley
Marshall Wace
Robeco Investment Management
Northern Trust
Jacobs Levy Equity Management
T. Rowe Price Associates
Citadel Advisors
Voloridge Investment Management

View all funds holding Catalyst Pharmaceutical Partners